As we navigate the healthcare landscape of 2026, the economic footprint of autoimmune care has reached unprecedented levels. The increasing prevalence of systemic inflammatory conditions, coupled with a surge in diagnostic accuracy, has fundamentally altered the financial trajectory of the sector. Current industry data suggests that the Vasculitis Market Size is expanding at a robust compound...